BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38493882)

  • 1. WDR4 promotes HCC pathogenesis through N
    Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
    Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
    Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
    Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
    Li R; Liu X; Deng K; Wang X
    BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
    Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
    Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL1 promotes hepatocarcinogenesis via m
    Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
    Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma.
    Xia P; Zhang H; Xu K; Jiang X; Gao M; Wang G; Liu Y; Yao Y; Chen X; Ma W; Zhang Z; Yuan Y
    Cell Death Dis; 2021 Jul; 12(7):691. PubMed ID: 34244479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL1/WDR4-mediated tRNA m
    Wang Z; Yu P; Zou Y; Ma J; Han H; Wei W; Yang C; Zheng S; Guo S; Wang J; Liu L; Lin S
    Oncogene; 2023 Jun; 42(23):1900-1912. PubMed ID: 37185458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL1 mediated tRNA m
    Zhao P; Xia L; Chen D; Xu W; Guo H; Xu Y; Yan B; Wu X; Li Y; Zhang Y; Zhang X
    Exp Hematol Oncol; 2024 Jan; 13(1):8. PubMed ID: 38268051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL1/WDR4-mediated m
    Ma J; Han H; Huang Y; Yang C; Zheng S; Cai T; Bi J; Huang X; Liu R; Huang L; Luo Y; Li W; Lin S
    Mol Ther; 2021 Dec; 29(12):3422-3435. PubMed ID: 34371184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis of regulated m
    Li J; Wang L; Hahn Q; Nowak RP; Viennet T; Orellana EA; Roy Burman SS; Yue H; Hunkeler M; Fontana P; Wu H; Arthanari H; Fischer ES; Gregory RI
    Nature; 2023 Jan; 613(7943):391-397. PubMed ID: 36599985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P300/SP1 complex mediating elevated METTL1 regulates CDK14 mRNA stability via internal m7G modification in CRPC.
    Zhang M; Kan D; Zhang B; Chen X; Wang C; Chen S; Gao W; Yang Z; Li Y; Chen Y; Zhu S; Wen S; Niu Y; Shang Z
    J Exp Clin Cancer Res; 2023 Aug; 42(1):215. PubMed ID: 37599359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting N
    Zhu S; Wu Y; Zhang X; Peng S; Xiao H; Chen S; Xu L; Su T; Kuang M
    Mol Ther; 2023 Jun; 31(6):1596-1614. PubMed ID: 35965412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N
    Han H; Yang C; Ma J; Zhang S; Zheng S; Ling R; Sun K; Guo S; Huang B; Liang Y; Wang L; Chen S; Wang Z; Wei W; Huang Y; Peng H; Jiang YZ; Choe J; Lin S
    Nat Commun; 2022 Mar; 13(1):1478. PubMed ID: 35304469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mettl1/Wdr4-Mediated m
    Lin S; Liu Q; Lelyveld VS; Choe J; Szostak JW; Gregory RI
    Mol Cell; 2018 Jul; 71(2):244-255.e5. PubMed ID: 29983320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL1 Promotes let-7 MicroRNA Processing via m7G Methylation.
    Pandolfini L; Barbieri I; Bannister AJ; Hendrick A; Andrews B; Webster N; Murat P; Mach P; Brandi R; Robson SC; Migliori V; Alendar A; d'Onofrio M; Balasubramanian S; Kouzarides T
    Mol Cell; 2019 Jun; 74(6):1278-1290.e9. PubMed ID: 31031083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N
    Dai Z; Liu H; Liao J; Huang C; Ren X; Zhu W; Zhu S; Peng B; Li S; Lai J; Liang L; Xu L; Peng S; Lin S; Kuang M
    Mol Cell; 2021 Aug; 81(16):3339-3355.e8. PubMed ID: 34352206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structures and mechanisms of tRNA methylation by METTL1-WDR4.
    Ruiz-Arroyo VM; Raj R; Babu K; Onolbaatar O; Roberts PH; Nam Y
    Nature; 2023 Jan; 613(7943):383-390. PubMed ID: 36599982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N
    Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
    Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel roles of METTL1/WDR4 in tumor via m
    Cheng W; Gao A; Lin H; Zhang W
    Mol Ther Oncolytics; 2022 Sep; 26():27-34. PubMed ID: 35784404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
    Li T; Chen Z; Wang Z; Lu J; Chen D
    Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.